Reliance Chemotex Industries Ltd

Reliance Chemotex Industries Management Change

Reliance Chemotex Industries re-appointed Mr. Sanjiv Shroff as Executive Director for a 36-month term, effective September 1, 2026.

Reliance Chemotex Industries Annual General Meeting

Reliance Chemotex Industries Ltd held its 48th Annual General Meeting on September 24, 2026, where members transacted business, including the declaration of a final dividend.

Reliance Chemotex Industries Annual General Meeting

Reliance Chemotex Industries Ltd has filed the notice for its 48th Annual General Meeting, scheduled for September 24, 2026, alongside the Annual Report for FY2025-26.

Reliance Chemotex Industries Management Change

Reliance Chemotex Industries Ltd. has approved the re-appointment of Mr. Sanjiv Shroff as Managing Director. His new three-year term commences on September 1, 2026.

Execution

3 years

Reliance Chemotex Industries Annual General Meeting

Reliance Chemotex Industries Ltd announced September 18, 2026, as the record date for its 48th AGM and dividend payment. Book closure is scheduled from September 18-24, 2026.

Reliance Chemotex Industries Q1 FY27 Results: Net Profit ₹1.4 Cr, Up 27.3% YoY

Reliance Chemotex Industries Ltd reported revenue from operations of ₹98.8 Cr (+6.9% YoY) and net profit of ₹1.4 Cr (+27.3% YoY) for Q1 FY27.

Key figure

Net profit ₹1.4 Cr · +27.3% YoY

Reliance Chemotex Industries Board Meeting Date

Reliance Chemotex Industries scheduled a board meeting for August 11, 2026. The board will consider Q1 financial results and the 48th Annual General Meeting details.

Reliance Chemotex Industries Other Announcement

Reliance Chemotex Industries disclosed its quarterly shareholding pattern as of June 30, 2026. Promoter and body corporate holdings are detailed per Regulation 31(1)(b).

Reliance Chemotex Industries Other Announcement

The company reminded shareholders to update KYC details and warned of IEPF transfer for unclaimed dividends. Investors should act promptly to avoid loss of shares.

Reliance Chemotex Industries Other Announcement

Reliance Chemotex Industries amended its Fair Disclosure Code for Unpublished Price Sensitive Information. Approved by the Board, the policy aligns with updated SEBI Insider Trading Regulations.

Reliance Chemotex Industries Board Meeting Outcome

Reliance Chemotex Industries approved the re-appointment of its cost and internal auditors for 12-month terms. The decision ensures continuity in the company's financial oversight and compliance.

Execution

12 months

Reliance Chemotex Industries Dividend

Reliance Chemotex Industries recommended a final dividend of ₹0.5 per equity share for FY 2025-26. Record and AGM dates will be finalized later.

Reliance Chemotex Industries Management Change

Reliance Chemotex Industries re-appointed its Internal and Cost Auditors for the 2026-27 financial year. The Board approved these appointments to ensure continued regulatory and internal compliance.

Execution

Financial year 2026-27

Reliance Chemotex Industries Q4 FY26 Results: Net Profit ₹1.7 Cr, Down 5.6% YoY

Reliance Chemotex Industries Ltd reported revenue from operations of ₹88.2 Cr (+7.3% YoY) and net profit of ₹1.7 Cr (-5.6% YoY) for Q4 FY26.

Key figure

Net profit ₹1.7 Cr · -5.6% YoY

Reliance Chemotex Industries Financial Results

Reliance Chemotex approved its FY26 audited results and recommended a 5% dividend. The company also transitioned to a new tax regime, providing future tax concessions.

Value

₹0.38 Cr

Reliance Chemotex Industries Board Meeting Date

Reliance Chemotex scheduled a board meeting on May 29, 2026, to approve FY26 results and consider a final dividend. Investors should monitor the dividend announcement.

Reliance Chemotex Industries Annual General Meeting

Reliance Chemotex Industries Ltd announced the results of its postal ballot conducted via remote e-voting. Shareholders approved the re-appointment of Mr. Ram Niwas Sharma as a Non-Executive Independent Director with a 99.99% majority. The scrutinizer confirmed the process was fair and transparent.